T-cell acute lymphoblastic leukemia
(Redirected from T-Cell Acute Lymphoblastic Leukemia)
T-cell acute lymphoblastic leukemia (T-ALL) is a subtype of acute lymphoblastic leukemia (ALL), a cancer of the white blood cells. T-ALL affects T cells, a type of lymphocyte that plays a key role in the immune response.
Epidemiology[edit | edit source]
T-ALL accounts for approximately 15% of ALL cases in children and 25% in adults. It is more common in males than in females, and its incidence peaks in adolescence.
Pathophysiology[edit | edit source]
T-ALL is characterized by the malignant transformation and proliferation of immature T cells, or T lymphoblasts. This is often associated with genetic abnormalities, such as translocations and mutations, that disrupt normal T cell development.
Clinical presentation[edit | edit source]
Patients with T-ALL typically present with signs and symptoms of bone marrow failure, such as fatigue, pallor, and bleeding, as well as lymphadenopathy, hepatosplenomegaly, and sometimes mediastinal mass.
Diagnosis[edit | edit source]
The diagnosis of T-ALL is based on the morphological, immunophenotypic, and genetic analysis of peripheral blood and bone marrow samples. The presence of T lymphoblasts in these samples is indicative of T-ALL.
Treatment[edit | edit source]
The treatment of T-ALL involves intensive chemotherapy, often followed by stem cell transplantation in high-risk cases. Despite advances in treatment, the prognosis of T-ALL remains poor, particularly in adults.
Prognosis[edit | edit source]
The prognosis of T-ALL is generally worse than that of B-cell ALL, with lower rates of complete remission and higher rates of relapse. However, recent advances in treatment have improved the prognosis of T-ALL, particularly in children.
See also[edit | edit source]
T-cell acute lymphoblastic leukemia Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Bonnu, Prab R. Tumpati, MD